Cargando…
Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic
BACKGROUND: Heterozygous mutations in the HNF1B gene are the most common monogenic cause of developmental kidney disease. Extrarenal phenotypes frequently occur, including diabetes mellitus and pancreatic hypoplasia; the latter is associated with subclinical exocrine dysfunction. We measured faecal...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070112/ https://www.ncbi.nlm.nih.gov/pubmed/30094008 http://dx.doi.org/10.1093/ckj/sfx150 |
_version_ | 1783343622747324416 |
---|---|
author | Clissold, Rhian L Fulford, Jon Hudson, Michelle Shields, Beverley M McDonald, Timothy J Ellard, Sian Hattersley, Andrew T Bingham, Coralie |
author_facet | Clissold, Rhian L Fulford, Jon Hudson, Michelle Shields, Beverley M McDonald, Timothy J Ellard, Sian Hattersley, Andrew T Bingham, Coralie |
author_sort | Clissold, Rhian L |
collection | PubMed |
description | BACKGROUND: Heterozygous mutations in the HNF1B gene are the most common monogenic cause of developmental kidney disease. Extrarenal phenotypes frequently occur, including diabetes mellitus and pancreatic hypoplasia; the latter is associated with subclinical exocrine dysfunction. We measured faecal elastase-1 in patients with HNF1B-associated disease regardless of diabetes status and assessed the degree of symptoms associated with pancreatic exocrine deficiency. METHODS: Faecal elastase-1 was measured in 29 patients with a known HNF1B mutation. We defined a low faecal elastase-1 concentration based on the 2.5 percentile of 99 healthy control individuals (410 μg/g stool). Symptoms related to pancreatic exocrine dysfunction were assessed and a subset of the HNF1B cohort (n = 6) underwent pancreatic imaging. RESULTS: Faecal elastase-1 was below the 2.5 percentile of the control cohort in 18/29 (62%) patients with HNF1B-associated renal disease. A total of 8/29 (28%) had a measurement suggestive of exocrine pancreatic insufficiency at <200 μg/g stool; of these, 3 suffered with abdominal pain, loose stools and/or unintentional weight loss. All three experienced symptomatic improvement and weight gain after commencing pancreatic enzyme replacement therapy. Faecal elastase-1 was low in 7/15 (47%) HNF1B patients without diabetes compared with 11/14 (79%) of those with diabetes (P = 0.1). CONCLUSIONS: Faecal elastase-1 deficiency is a common feature of HNF1B-associated renal disease even when diabetes is not present and pancreatic exocrine deficiency may be more symptomatic than previously suggested. Faecal elastase-1 should be measured in all patients with known HNF1B-associated disease complaining of chronic abdominal pain, loose stools or unintentional weight loss. The discovery of a low faecal elastase-1 concentration in individuals with developmental kidney disease of uncertain cause should prompt referral for HNF1B genetic testing. |
format | Online Article Text |
id | pubmed-6070112 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60701122018-08-09 Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic Clissold, Rhian L Fulford, Jon Hudson, Michelle Shields, Beverley M McDonald, Timothy J Ellard, Sian Hattersley, Andrew T Bingham, Coralie Clin Kidney J Genetic Kidney Diseases BACKGROUND: Heterozygous mutations in the HNF1B gene are the most common monogenic cause of developmental kidney disease. Extrarenal phenotypes frequently occur, including diabetes mellitus and pancreatic hypoplasia; the latter is associated with subclinical exocrine dysfunction. We measured faecal elastase-1 in patients with HNF1B-associated disease regardless of diabetes status and assessed the degree of symptoms associated with pancreatic exocrine deficiency. METHODS: Faecal elastase-1 was measured in 29 patients with a known HNF1B mutation. We defined a low faecal elastase-1 concentration based on the 2.5 percentile of 99 healthy control individuals (410 μg/g stool). Symptoms related to pancreatic exocrine dysfunction were assessed and a subset of the HNF1B cohort (n = 6) underwent pancreatic imaging. RESULTS: Faecal elastase-1 was below the 2.5 percentile of the control cohort in 18/29 (62%) patients with HNF1B-associated renal disease. A total of 8/29 (28%) had a measurement suggestive of exocrine pancreatic insufficiency at <200 μg/g stool; of these, 3 suffered with abdominal pain, loose stools and/or unintentional weight loss. All three experienced symptomatic improvement and weight gain after commencing pancreatic enzyme replacement therapy. Faecal elastase-1 was low in 7/15 (47%) HNF1B patients without diabetes compared with 11/14 (79%) of those with diabetes (P = 0.1). CONCLUSIONS: Faecal elastase-1 deficiency is a common feature of HNF1B-associated renal disease even when diabetes is not present and pancreatic exocrine deficiency may be more symptomatic than previously suggested. Faecal elastase-1 should be measured in all patients with known HNF1B-associated disease complaining of chronic abdominal pain, loose stools or unintentional weight loss. The discovery of a low faecal elastase-1 concentration in individuals with developmental kidney disease of uncertain cause should prompt referral for HNF1B genetic testing. Oxford University Press 2018-08 2018-01-30 /pmc/articles/PMC6070112/ /pubmed/30094008 http://dx.doi.org/10.1093/ckj/sfx150 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Genetic Kidney Diseases Clissold, Rhian L Fulford, Jon Hudson, Michelle Shields, Beverley M McDonald, Timothy J Ellard, Sian Hattersley, Andrew T Bingham, Coralie Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
title | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
title_full | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
title_fullStr | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
title_full_unstemmed | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
title_short | Exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
title_sort | exocrine pancreatic dysfunction is common in hepatocyte nuclear factor 1β-associated renal disease and can be symptomatic |
topic | Genetic Kidney Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070112/ https://www.ncbi.nlm.nih.gov/pubmed/30094008 http://dx.doi.org/10.1093/ckj/sfx150 |
work_keys_str_mv | AT clissoldrhianl exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT fulfordjon exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT hudsonmichelle exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT shieldsbeverleym exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT mcdonaldtimothyj exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT ellardsian exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT hattersleyandrewt exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic AT binghamcoralie exocrinepancreaticdysfunctioniscommoninhepatocytenuclearfactor1bassociatedrenaldiseaseandcanbesymptomatic |